GSK drug test approved by UK to treat COVID19

Scientists discovered the new omicron strain previous week which doubled in a day, making the Omicron surge in the nation.

0
252

New Delhi: Authorities in the United Kingdom have shown green flag to the use of monoclonal therapy, known as sotrovimab, to those individuals who are at a higher risk of having severe COVID19 infection symptoms. The manufacturer of the drugs, GlaxoSmithKline stated it “retains activity” against the new coronavirus variant Omicron.

The news followed as South Korea’s daily COVID19 cases toll increased to a peak with the officials halting quarantine exemptions for fully jabbed international travellers for almost two weeks to curb the new variant’s spread.

The US is left frightened over the impact of the ‘highly mutant’ coronavirus strain as the nation reported its first Omicron virus case in a fully vaccinated person from California. The individual returned from South Africa on November 22 and was tested positive after seven days.

Scientists discovered the new omicron strain previous week which doubled in a day, making the Omicron surge in the nation.

The World Health Organisation (WHO) stated that the information on how contagious Omicron is should be likely available “within days”, on the other hand, the Japanese central bank warned of economic despair as many countries are consolidating containment measures.

LEAVE A REPLY

Please enter your comment!
Please enter your name here